Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing
Qibin Liao(Shanghai Public Health Clinical Center), Jianqing Xu(Fudan University)
Cited by 40
Related Papers
Conditioned CAR-T cells by hypoxia-inducible transcription amplification (HiTA) system significantly enhances systemic safety and retains antitumor efficacy
|Journal for ImmunoTherapy of Cancer|2021|54
Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors
|Frontiers in Bioengineering and Biotechnology|2022|9